GeneThera
Tokyo, Japan· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $90M
Overview
A Japanese biotech integrating gene therapy and diagnostics for rare genetic diseases.
Gene TherapyDiagnosticsGenetics & Genomics
Technology Platform
An integrated platform combining gene therapy vector engineering with companion diagnostic development for targeted rare genetic diseases.
Funding History
1Total raised:$90M
Public Offering$90M
Opportunities
Leveraging an integrated therapy-diagnostic model to efficiently address rare genetic diseases with high unmet need.
Risk Factors
Faces the high costs, complex manufacturing, and stringent safety regulations inherent to gene therapy development.
Competitive Landscape
Competes in the global gene therapy arena, particularly against companies focused on rare monogenic diseases.